These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28199524)

  • 21. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
    Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH
    BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S; Ishikawa Y; Yamaguchi H; Shiosakai K
    J Infect Chemother; 2018 Sep; 24(9):707-712. PubMed ID: 29759897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.
    Hirotsu N; Saisho Y; Hasegawa T
    Influenza Other Respir Viruses; 2019 Mar; 13(2):123-132. PubMed ID: 29989680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
    Kawai N; Ikematsu H; Tanaka O; Matsuura S; Maeda T; Yamauchi S; Hirotsu N; Nishimura M; Iwaki N; Kashiwagi S
    J Infect Chemother; 2011 Jun; 17(3):375-81. PubMed ID: 21120678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults.
    Ergönül Ö; Alan S; Ak Ö; Sargın F; Kantürk A; Gündüz A; Engin D; Öncül O; Balkan II; Ceylan B; Benzonana N; Yazıcı S; Şimşek F; Uzun N; Inan A; Gulhan E; Ciblak M; Midilli K; Ozyurt M; Badur S; Gencer S; Nazlıcan O; Özer S; Özgüneş N; Yıldırmak T; Aslan T; Göktaş P; Saltoğlu N; Fincancı M; Dokucu AI; Eraksoy H; ;
    BMC Infect Dis; 2014 Jun; 14():317. PubMed ID: 24916566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.
    Louie JK; Yang S; Acosta M; Yen C; Samuel MC; Schechter R; Guevara H; Uyeki TM
    Clin Infect Dis; 2012 Nov; 55(9):1198-204. PubMed ID: 22843781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
    Monto AS; McKimm-Breschkin JL; Macken C; Hampson AW; Hay A; Klimov A; Tashiro M; Webster RG; Aymard M; Hayden FG; Zambon M
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2395-402. PubMed ID: 16801417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus.
    Huang SF; Fung CP; Perng DW; Wang FD
    J Microbiol Immunol Infect; 2017 Oct; 50(5):586-594. PubMed ID: 26542650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.
    Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
    J Infect Chemother; 2015 Jan; 21(1):39-42. PubMed ID: 25277670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of influenza with neuraminidase inhibitors.
    Beard KR; Brendish NJ; Clark TW
    Curr Opin Infect Dis; 2018 Dec; 31(6):514-519. PubMed ID: 30320639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.
    Hansen C; Desai S; Bredfeldt C; Cheetham C; Gallagher M; Li DK; Raebel MA; Riedlinger K; Shay DK; Thompson M; Davis RL
    J Infect Dis; 2012 Oct; 206(8):1260-8. PubMed ID: 22859826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.
    Huang W; Cheng Y; Li X; Tan M; Wei H; Zhao X; Xiao N; Dong J; Wang D
    J Infect Chemother; 2018 Sep; 24(9):729-733. PubMed ID: 29866491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Y155H amino acid substitution in influenza A(H1N1)pdm09 viruses does not confer a phenotype of reduced susceptibility to neuraminidase inhibitors.
    Perez-Sautu U; Pozo F; Cuesta I; Monzon S; Calderon A; Gonzalez M; Molinero M; Lopez-Miragaya I; Rey S; Cañizares A; Rodriguez G; Gonzalez-Velasco C; Lackenby A; Casas I
    Euro Surveill; 2014 Jul; 19(27):14-20. PubMed ID: 25033052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Chong Y; Bando T; Iwaki N; Kashiwagi S
    J Infect Chemother; 2019 Aug; 25(8):649-652. PubMed ID: 31101530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
    J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
    Ikematsu H; Kawai N; Kashiwagi S
    J Infect Chemother; 2012 Aug; 18(4):529-33. PubMed ID: 22370919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
    Okomo-Adhiambo M; Hurt AC; Gubareva LV
    Methods Mol Biol; 2012; 865():95-113. PubMed ID: 22528155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.